{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:05:21Z","timestamp":1791893121487,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,6]],"date-time":"2016-11-06T00:00:00Z","timestamp":1478390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Breast Cancer Foundation","doi-asserted-by":"publisher","award":["416170"],"award-info":[{"award-number":["416170"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["411333"],"award-info":[{"award-number":["411333"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbacli.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T17:30:19Z","timestamp":1485538219000},"page":"64-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["Understanding breast cancer \u2013 The long and winding road"],"prefix":"10.1016","volume":"7","author":[{"given":"Kiven Erique","family":"Lukong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbacli.2017.01.001_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0010","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-015-0487-4","article-title":"The epidemiology of male breast cancer","volume":"18","author":"Ferzoco","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"DeSantis","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0025","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/jocn.12368","article-title":"Breastfeeding and the prevention of breast cancer: a retrospective review of clinical histories","volume":"23","author":"Gonzalez-Jimenez","year":"2014","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0030","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0035","first-page":"560","article-title":"Commentary on the significance for modern neurology of the 17th century B.C. Surgical Papyrus","volume":"14","author":"Helgason","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0040","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00701-012-1523-x","article-title":"On the myth of the Edwin Smith papyrus: is it magic or science?","volume":"154","author":"Brawanski","year":"2012","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0045","series-title":"Breast Cancer: Cause, Prevention, Cure","first-page":"440","author":"Harding","year":"2007"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0050","series-title":"History of Breast Cancer Therapy, Medical Therapy of Breast Cancer","author":"Rayter","year":"2003"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0055","first-page":"349","article-title":"A short history of breast-cancer - Demoulin, D","volume":"8","author":"Crouch","year":"1984","journal-title":"Community Health Stud."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jhmas\/39.1.100","article-title":"A short history of breast-cancer \u2013 Demoulin, D","volume":"39","author":"Olch","year":"1984","journal-title":"J. Hist. Med. Allied Sci."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0065","first-page":"417","article-title":"A short history of breast-cancer \u2013 Demoulin, D, B","volume":"58","author":"Petrakis","year":"1984","journal-title":"Hist. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0070","series-title":"A Treatise on the Diseases of Breast","author":"Velpeau","year":"1876"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0075","unstructured":"H. Amjad, Q.-A. Amjad, History of Breast Cancer, Country and Natural Medicine Newsletter."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1245\/s10434-009-0886-6","article-title":"Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer","volume":"17","author":"Papavramidou","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-011-1787-5","article-title":"Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis","volume":"132","author":"Chen","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0090","series-title":"Opera Omnia. Lipsiae: Car","first-page":"139","article-title":"Ad glauconeum de methodo medendi","volume":"11","author":"Galen","year":"1826"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0095","first-page":"1","article-title":"History of breast cancer","author":"Donegan","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0100","first-page":"116","article-title":"De atra bile","volume":"5","author":"Galen","year":"1823"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0149-7944(02)00777-8","article-title":"History of surgery for breast cancer: radical to the sublime","volume":"60","author":"Cotlar","year":"2003","journal-title":"Curr. Surg."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0110","first-page":"186","article-title":"Who discovered the lymphatic system","volume":"30","author":"Chikly","year":"1997","journal-title":"Lymphology"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.55.8.727","article-title":"Franciscus de le Boe or Sylvius 1614\u201372","volume":"55","author":"Haas","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00381-006-0265-6","article-title":"Franciscus Sylvius (1614-1672): a historical review","volume":"23","author":"Tubbs","year":"2007","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/01.brs.0000142437.70429.a8","article-title":"Bernardino Ramazzini: the father of occupational medicine","volume":"29","author":"Pope","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI25456","article-title":"Bathsheba's breast women, cancer & history","volume":"115","author":"Mandell","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0135","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/bmj.2.1918.890","article-title":"On oophorectomy in the treatment of cancer","volume":"2","author":"Boyd","year":"1897","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/EDE.0b013e3181e08eb3","article-title":"Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931","volume":"21","author":"Press","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0145","article-title":"A comparison of conditions associated with breast cancer in Great Britain and America","volume":"15","author":"Wainwright","year":"1931","journal-title":"Am. J. Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0150","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1136\/fn.84.2.F138","article-title":"Wilhelm Conrad Roentgen (1845\u20131923), the discovery of x rays and perinatal diagnosis","volume":"84","author":"Dunn","year":"2001","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0155","first-page":"1613","article-title":"History of mammography","volume":"182","author":"Picard","year":"1998","journal-title":"Bull. Acad. Natl Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2214\/ajr.150.3.493","article-title":"The evolution of mammography","volume":"150","author":"Bassett","year":"1988","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0165","doi-asserted-by":"crossref","first-page":"VII","DOI":"10.1590\/0100-3984.2014.47.4e2","article-title":"Mammography: a history of success and scientific enthusiasm","volume":"47","author":"Kalaf","year":"2014","journal-title":"Radiol. Bras."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198503143121101","article-title":"Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer","volume":"312","author":"Fisher","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM198503143121102","article-title":"Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation","volume":"312","author":"Fisher","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0180","first-page":"2371","article-title":"The evolution of paradigms for the management of breast cancer: a personal perspective","volume":"52","author":"Fisher","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0185","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ewjm.174.5.362","article-title":"No shrinking violet: Rose Kushner and the rise of American breast cancer activism","volume":"174","author":"Lerner","year":"2001","journal-title":"West. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.bbacli.2017.01.001_bb0190","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1046\/j.1524-4741.9.s2.13.x","article-title":"The history of breast cancer advocacy","volume":"9","author":"Braun","year":"2003","journal-title":"Breast J."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.embor.7400444","article-title":"One hundred years of hormones","volume":"6","author":"Tata","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.physbeh.2009.08.013","article-title":"Estrogen action: a historic perspective on the implications of considering alternative approaches","volume":"99","author":"Jensen","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0205","first-page":"45","article-title":"Hormone receptors: studies on the interaction of estrogen with the uterus","volume":"24","author":"Gorski","year":"1968","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0215","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1071-5576(99)00054-4","article-title":"Selective estrogen receptor modulators (SERMs) in clinical practice","volume":"7","author":"Plouffe","year":"2000","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0230","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0235","first-page":"787","article-title":"Breast cancer genes: looking for BRACA's lost brother","volume":"16","author":"Cornejo-Moreno","year":"2014","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0240","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.bjc.6600840","article-title":"BRCA1 and BRCA2 mutations in Scotland and Northern Ireland","volume":"88","author":"B.B.C. Scottish\/Northern Irish","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.bi.48.070179.001205","article-title":"Epidermal growth factor","volume":"48","author":"Carpenter","year":"1979","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/319230a0","article-title":"Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor","volume":"319","author":"Yamamoto","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(88)90184-5","article-title":"Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene","volume":"54","author":"Muller","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0265","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0270","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0275","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00313020802563510","article-title":"Triple-negative\/basal-like breast cancer: review","volume":"41","author":"Rakha","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"Prat","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0295","first-page":"240","article-title":"WHO Classification of Tumours","volume":"vol. 4","author":"Lakhani","year":"2012"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0300","series-title":"Focusing on Issues and Updates from the 3rd Edition","first-page":"149","article-title":"A brief overview of the WHO classification of breast tumors","volume":"8","author":"Sinn","year":"2013"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0305","first-page":"300","article-title":"Risk factors. Oncotype DX assay predicts local recurrence in breast cancer, Nat rev","volume":"7","author":"Kirk","year":"2010","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0310","first-page":"12","article-title":"Oncotype DX test offers guidance for women debating chemotherapy","volume":"3","author":"Carlson","year":"2006","journal-title":"Biotechnol. Healthc."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yasu.2008.03.002","article-title":"Gene expression profiling of breast cancer","volume":"42","author":"Bao","year":"2008","journal-title":"Adv. Surg."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CCO.0b013e3282f0ada3","article-title":"Gene expression profiling in breast cancer","volume":"19","author":"Morris","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1677\/erc.0.0070017","article-title":"Similarities and distinctions in the mode of action of different classes of antioestrogens","volume":"7","author":"Wakeling","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0330","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2014.04.018","article-title":"Estrogen metabolism and breast cancer","volume":"356","author":"Samavat","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/BOR.0b013e32832ca447","article-title":"New selective estrogen and androgen receptor modulators","volume":"21","author":"Clarke","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-med-042513-015127","article-title":"Targeting HER2 for the treatment of breast cancer","volume":"66","author":"Rimawi","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-med-070912-143853","article-title":"Molecular testing in breast cancer","volume":"65","author":"Paoletti","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0355","first-page":"59","article-title":"Current Strategies for the Prevention of Breast Cancer","volume":"6","author":"Advani","year":"2014"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0360","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0365","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","article-title":"The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services","volume":"16","author":"Evans","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-011-1479-1","article-title":"The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer","volume":"128","author":"Narod","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0375","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0380","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study","volume":"14","author":"Swain","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0385","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/clpt.2014.24","article-title":"Exposure-response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer","volume":"95","author":"Wang","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0390","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1021\/jm500766w","article-title":"Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer","volume":"57","author":"Lambert","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0395","article-title":"Treatment of HER2 positive advanced breast cancer with T-DM1: a review of the literature","author":"Martinez","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbacli.2015.03.003","article-title":"The fate of chemoresistance in triple negative breast cancer (TNBC)","volume":"3","author":"O'Reilly","year":"2015","journal-title":"BBA Clin."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0410","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer--current status and future directions","volume":"20","author":"Gluz","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0415","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","author":"Denkert","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0425","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1039\/C6MB00639F","article-title":"Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer","volume":"13","author":"Miah","year":"2016","journal-title":"Mol. BioSyst."},{"issue":"Suppl. 6","key":"10.1016\/j.bbacli.2017.01.001_bb0430","doi-asserted-by":"crossref","first-page":"vi56","DOI":"10.1093\/annonc\/mds196","article-title":"Emerging targeted therapies in triple-negative breast cancer","volume":"23","author":"Crown","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0435","first-page":"646","article-title":"Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer","volume":"13","author":"Liang","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.bbacli.2017.01.001_bb0440","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/eci.12276","article-title":"Cancer stem cells and their implication in breast cancer","volume":"44","author":"Carrasco","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0445","article-title":"Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment","author":"Wu","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.NONRNA15-PR11","article-title":"Differentiation of mammary tumors and reduction in metastasis upon Malat1 LncRNA loss","volume":"76","author":"Arun","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0455","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMcibr1603785","article-title":"Targeting a long noncoding RNA in breast cancer","volume":"374","author":"Mendell","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0460","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1402012111","article-title":"Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter","author":"Le","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.bbacli.2017.01.001_bb0465","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.jvir.2015.07.020","article-title":"Percutaneous image-guided cryoablation of breast cancer: a systematic review","volume":"26","author":"Lanza","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0470","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13058-015-0542-y","article-title":"Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA","volume":"17","author":"Hayes","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0475","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbacli.2017.01.001_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081357","article-title":"Tamoxifen resistance: emerging molecular targets","volume":"17","author":"Rondon-Lagos","year":"2016","journal-title":"Int. J. Mol. Sci."}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221464741630054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221464741630054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T22:26:29Z","timestamp":1601504789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221464741630054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":96,"alternative-id":["S221464741630054X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2017.01.001","relation":{},"ISSN":["2214-6474"],"issn-type":[{"value":"2214-6474","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding breast cancer \u2013 The long and winding road","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}